In our weekly check, Incyte Corporation is graded B (A to F). Of 24 checks on debt, profit, cash flow and trend: 18 pass, warnings: 4, red flags: 2.
Incyte Corporation is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as INCY.
Next earnings report: 2027-02-09
UTHR · INSM · ALNY · ROIV · BNTX · GMAB
In our weekly check, Incyte Corporation is graded B (A to F). Of 24 checks on debt, profit, cash flow and trend: 18 pass, warnings: 4, red flags: 2. The grade is a risk check, not a buy or sell recommendation.
This week's biggest flags for Incyte Corporation: Margins falling, Deep past fall, Gross margin falling. In total 6 of 24 checks show a warning or a red flag.
Incyte Corporation is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as INCY.
The next earnings report is expected on 2027-02-09. We re-run the checks every week, so the grade can change after it.
The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.
Updated 2026-11-14